AQR Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$398K Buy
231,657
+172,117
+289% +$296K ﹤0.01% 2726
2025
Q1
$195K Buy
59,540
+43,829
+279% +$144K ﹤0.01% 2896
2024
Q4
$114K Buy
+15,711
New +$114K ﹤0.01% 2755
2024
Q3
Sell
-11,477
Closed -$92K 2823
2024
Q2
$92K Sell
11,477
-28,534
-71% -$229K ﹤0.01% 2501
2024
Q1
$583K Buy
+40,011
New +$583K ﹤0.01% 1908
2023
Q2
Sell
-84,325
Closed -$515K 2234
2023
Q1
$515K Buy
84,325
+34,576
+70% +$211K ﹤0.01% 1771
2022
Q4
$308K Buy
+49,749
New +$308K ﹤0.01% 1963
2021
Q2
Sell
-34,022
Closed -$1.06M 2262
2021
Q1
$1.06M Sell
34,022
-5,077
-13% -$158K ﹤0.01% 1525
2020
Q4
$1.81M Buy
39,099
+8,689
+29% +$403K ﹤0.01% 1214
2020
Q3
$987K Sell
30,410
-79,292
-72% -$2.57M ﹤0.01% 1407
2020
Q2
$3.01M Buy
109,702
+42,489
+63% +$1.17M ﹤0.01% 979
2020
Q1
$2.01M Buy
67,213
+24,361
+57% +$729K ﹤0.01% 1069
2019
Q4
$1.19M Buy
42,852
+17,655
+70% +$489K ﹤0.01% 1456
2019
Q3
$459K Buy
+25,197
New +$459K ﹤0.01% 1780
2019
Q1
Sell
-33,573
Closed -$297K 2185
2018
Q4
$297K Sell
33,573
-13,119
-28% -$116K ﹤0.01% 1965
2018
Q3
$525K Buy
46,692
+7,293
+19% +$82K ﹤0.01% 1941
2018
Q2
$504K Buy
+39,399
New +$504K ﹤0.01% 1976
2016
Q4
Sell
-14,630
Closed -$120K 2259
2016
Q3
$120K Hold
14,630
﹤0.01% 2215
2016
Q2
$119K Sell
14,630
-7,648
-34% -$62.2K ﹤0.01% 2156
2016
Q1
$113K Hold
22,278
﹤0.01% 2180
2015
Q4
$172K Sell
22,278
-12,944
-37% -$99.9K ﹤0.01% 2176
2015
Q3
$203K Buy
35,222
+4,454
+14% +$25.7K ﹤0.01% 2058
2015
Q2
$282K Buy
+30,768
New +$282K ﹤0.01% 2009